RecruitingPhase 1NCT05512390

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Studying B-cell chronic lymphocytic leukemia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AbbVie
Principal Investigator: ABBVIE INC.
AbbVie
Intervention: ABBV-319(drug)
Enrollment: 154 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2027

Study locations (20)

University of Arizona Cancer Center - Tucson /ID# 247752, Tucson, Arizona, United States
Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232, Miami, Florida, United States
Allina Health System /ID# 251782, Minneapolis, Minnesota, United States
University of Nebraska Medical Center /ID# 246715, Omaha, Nebraska, United States
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 249246, New York, New York, United States
Novant Health Presbyterian Medical Center /ID# 246719, Charlotte, North Carolina, United States
Baylor Sammons Cancer Center /ID# 247715, Dallas, Texas, United States
University of Texas Health San Antonio MD Anderson Cancer Center /ID# 256234, San Antonio, Texas, United States
Concord Repatriation General Hospital /ID# 249240, Concord, New South Wales, Australia
St Vincent's Hospital Melbourne /ID# 247624, Fitzroy Melbourne, Victoria, Australia
One Clinical Research Pty Ltd /ID# 248392, Nedlands, Western Australia, Australia
Cross Cancer Institute /ID# 246717, Edmonton, Alberta, Canada
University Health Network_Princess Margaret Cancer Centre /ID# 243936, Toronto, Ontario, Canada
The Chaim Sheba Medical Center /ID# 254884, Ramat Gan, Tel Aviv, Israel
Hadassah Medical Center-Hebrew University /ID# 254885, Jerusalem, Israel
+5 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05512390 on ClinicalTrials.gov

Other trials for B-cell chronic lymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for B-cell chronic lymphocytic leukemia →

← Back to all trials